Antiviral drugs for the treatment of HIV-seropositive patients:<br /> nephrotoxicity and dose adjustments in renal insufficiency
Journal Title: Αρχεία Ελληνικής Ιατρικής - Year 2003, Vol 20, Issue 4
Abstract
Patients with HIV infection and HIV-related opportunistic infections and malignancies are treated extensively with a broad spectrum of drugs. The introduction of new antiretroviral drugs, such as protease inhibitors and non nucleoside reverse transcriptase inhibitors, has changed the therapeutic options of these patients. On the other hand, renal dysfunction of varied etiology is also common in HIV-infected patients and can lead to endstage renal disease (ESRD). Renal disease occurs both as a primary manifestation of HIV infection (HIVAN) and secondary to complications such as concurrent illness or drug therapy. Great progress has been made in identifying specific glomerular lesions and their pathogenesis. Although the underlying mechanism and management of these disorders appear to be unclear and multifactorial, the newer antiretroviral agents show promise in preventing or resolving established renal disease. In contrast with previous years, more physicians are now encouraged by recent favorable results in managing patients with HIV infection and renal failure with more aggressive antiretroviral therapy. The knowledge of drug toxicity and pharmacokinetics in HIV (+) patients with renal insufficiency is therefore crucial. Some drugs used in HIV infection are excreted primarily by the kidney, other drugs such as foscarnet, adefovir, cidofovir are directly nephrotoxic, whereas acyclovir and indinavir may cause crystal-induced acute renal failure. This article reviews the types of nephrotoxicity which antiviral drugs may produce and the impact of renal impairment on the different phases of pharmacokinetics (bioavailability, distribution, protein-binding, metabolism, elimination) of antiviral drugs used in HIV disease. It provides recommendations for dose adjustments necessary to avoid subtherapeutic and/or toxic levels
Authors and Affiliations
H. SAMBATAKOU
Delirium in the intensive care unit patient: A review of the current approaches to diagnosis and treatment
Delirium is an organic psychosyndrome which commonly develops in patients in the intensive care unit (ICU). Older patients suffer more often from the syndrome. It is recognized that delirium has a great impact on the dis...
Recent findings in the genetics of multiple sclerosis
The pathogenesis of multiple sclerosis (MS) is influenced by both genetic and environmental factors. Genetic factors can affect MS susceptibility or clinical expression. Findings from well-designed, population-based epid...
The Dundee Ready Education Environment Measure (DREEM) in Greek:<br /> How it should be used, and preliminary experience in the Greek medical educational environment <br /> <br />
OBJECTIVE The educational environment makes an important contribution to student learning. The Ready Education Environment Measure (DREEM) questionnaire which is an instrument for assessing this, has been translated into...
Rectus sheath hematoma (RSH)
No abstract available
History of mastectomy
Incidents of breast cancer have been documented back to the early Egyptians. Hippocrates was the first who used the term of cancer "karkinos" or "karkinoma" of the nose, the uterus, the breasts and the neck. He believed...